Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.
Congratulations to Pat Summitt for being awarded the Presidential Medal of Freedom! She has been a role model to millions of people throughout her career and has recently become a key figure in the fight against Alzheimer’s. Her courage in publicly announcing her diagnosis has brought needed awareness to the disease and stressed the importance of early detection. As a member of the Knoxville community, we are excited to support Pat Summitt and her foundation in the fight against Alzheimer’s disease.
Dr. Monica Crane, at the University of Tennessee Medical Center and Cole Neuroscience Center discusses Alzheimer’s Disease symptoms and treatment options in a short video produce by UT Medical Center.
Medinteract Co-founder, Dr. John Dougherty, was quoted in the article “Finding A Cure” by Alexander Wolf in the December 12, 2011 issue.
Excerpt – “Early diagnosis is so important,” says Dr. John Dougherty, who runs the Memory Clinic at the University of Tennessee’s Cole Neuroscience Center. “The goal is prevention through delay. If we can delay symptoms by five years with medication and exercise, we can reduce the number of sufferers by six- to eight million—[about] the population of metropolitan Atlanta.”
The two winningest coaches in Division I college basketball history (907 for him, 1,075 for her) have more in common than just extraordinary success. For reaching far beyond their campuses and refusing to be defined by their genders, SI honors them together.
Tech 2020′s Tennessee Valley Technology Council presented its annual Navigator Awards Wednesday, November 16, during the first day of the Entrepreneurial Imperative 2011 Conference. Awards of excellence were given for this year’s top entrepreneur, researcher, and technology company, as well as for the Tech Commericalization Champion of the year.
Selected as the 2011 Technology Company of the Year, Medinteract was cofounded by Andrew Dougherty. Medinteract provides efficient and effective detection of Alzheimer’s disease by their computer based cognitive screening testing technology. Early detection leads to early intervention delaying the impact of the disease. Medinteract is now providing their detection services to a range of medical service providers across the region.
Co-Founder of Medinteract, Dr. John Dougherty, was part of a check presentation to the UT Medical Center from the Pat Summit Foundation on behalf of the “We Back Pat” promotion at half time of the University of Tennessee versus Baylor game on Sunday, November 27, 2011. The event raised $150,000 and was generated grants to the UT Medical Center’s Brain and Spine Institute and Alzheimer’s Tennessee, Inc.
The Pat Summit Foundation Fund believes no family should have to hear a diagnosis like Pat’s: early onset dementia, Alzheimer’s type. The Fund will make grants to nonprofits which provide:
Education and awareness of Alzheimer’s its onset and treatment,
Support services to patients, their families and caregivers,
Research to treat, prevent, cure and ultimately eradicate this disease.
In 1983, a small group of East Tennessee families began to meet informally in an effort to understand and cope with the ravaging effects of Alzheimer’s disease. Together, the group was able to anticipate, confront, and solve seemingly insurmountable problems with a renewed sense of hope, confidence and accomplishment.
Alzheimer’s Tennessee, Inc. began providing services in East Tennessee as a non-profit organization in 1983. Two years later, the group affiliated with the Chicago-based National Alzheimer’s Association and became known as the Alzheimer’s Association, Eastern Tennessee Chapter, Inc. However, it always remained incorporated in the state of Tennessee and governed by a local Board of Directors.
The Eastern Tennessee Chapter of the Alzheimer’s Association returned to its original independent status in August 2011 to ensure that more resources support top research and local services for individuals and families struggling with the devastating disease.
The Cole Neuroscience Center is the only Neurology sub-specialty center of its kind in the region, The Cole Neuroscience Center offers a complete spectrum of care for degenerative neurological diseases, such as Alzheimer’s, Dementia, Movement Disorders, Parkinson’s, Multiple Sclerosis, Muscular Dystrophy, Amyotrophic Lateral Sclerosis and Epilepsy. Our specialists work together to develop treatment plans that assist the entire family. From access to the latest diagnostic tools and the newest clinical trials, to offering counseling and long-term care options, the Cole Neuroscience Center has so much to offer – especially hope. Each year the Cole Neuroscience Center serves more than 1400 patients with Parkinson’s disease, 2000 with Alzheimer’s disease and numerous others with neurodegenerative diseases.
KNOXVILLE (WATE) – Hundreds of people were at Sevier Heights Baptist Church Thursday to hear what a leading Alzheimer’s specialist had to say about the degenerative brain disease.
Dr. John Dougherty, with Cole Neuroscience Center at UT Medical Center, not only talked, he listened as people of all ages shared their stories about life with a loved one struggling with the mind-robbing disease.
As diagnostic criteria for Mild Cognitive Impairment (MCI) has become more widely embraced by the medical community, more and more patients are receiving a diagnosis and then asking the obvious question: what is it? This is generally followed by: does this mean I have (or will have) Alzheimer’s disease (AD)? Read More